News

Can This Silicon Valley Startup Bioengineer A Less Addictive Opioid?

Fast Company

Antheia receives Phase I SBIR award from the National Center for Complementary and Integrative Medicine to make non-narcotic cough suppressant

SBIR

Antheia receives Phase I SBIR award from the National Institute of Drug Abuse to make non-addictive opioid derivatives

SBIR

Antheia receives Phase I SBIR awards from the National Science Foundation to develop safer, more cost-effective manufacturing processes for essential painkillers

SBIR SBIR

The Scientist Who Uses Yeast to Brew Painkillers

OZY